$3.70
-0.05 | -1.34%
-0.05 | -1.34%
Today's Range:
3.69 -
3.73
PTIE Avg. Daily Volume:
169,700
05/30/12 - 10:37 AM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 3.75 |
| 52 Week High | 10.05 |
| 52 Week Low | 3.28 |
| Avg. Daily Vol. (Mil) | 0.17 |
| Beta (3 year) | 0.09 |
| Share Related Items | |
| Mkt Cap (Mil) | 167.75 |
| Shares Out (Mil) | 44.73 |
| Float (Mil) | 37.97 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 7.40 |
| Current Ratio | 7.40 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 14.95 |
| Price/Book | 3.70 |
| Price/Cash Flow | -75.20 |
| Per Share Data | |
| Earnings | -0.06 |
| Sales | 0.25 |
| Book Value | 1.01 |
| Cash Flow | -0.05 |
| Business Summary | |
|---|---|
| Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. It has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma. | |
| General Information | |
| 2211 Bridgepointe Parkway
Suite 500 San Mateo, CA 94404 |
|
| www.paintrials.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 10 | |
| CEO: Remi Barbier | |
| Short Interest | |
| Current Month (Mil) | 1.87 |
| Previous Month (Mil) | 1.85 |
| Short Interest Ratio (Days) | 14.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -2.50 |
| Return on Investments | -5.20 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | -21.20 |
| Profit Margin | -21.20 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,422.70 | 1,315.01 | 2,830.69 | 16.47 |
Oil *
103.54
|
|
DOWN
157.99 |
DOWN
17.41 |
DOWN
40.30 |
DOWN
0.84 |
10 Yr
1.65%
SPDR Gold
149.40
|
|
-1.26%
|
-1.31%
|
-1.40%
|
-4.85%
|
Data delayed 20 minutes |
Connect with TheStreet